Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$3.69B |
| 2 |
Abbott
ABT
|
+$3.65B |
| 3 |
Qualcomm
QCOM
|
+$3.54B |
| 4 |
Procter & Gamble
PG
|
+$3.42B |
| 5 |
Accenture
ACN
|
+$3.28B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$2.86B |
| 2 |
AbbVie
ABBV
|
+$2.71B |
| 3 |
Valero Energy
VLO
|
+$1.86B |
| 4 |
Lockheed Martin
LMT
|
+$916M |
| 5 |
Halliburton
HAL
|
+$856M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.91% |
| 2 | Financials | 10.68% |
| 3 | Healthcare | 10.19% |
| 4 | Industrials | 8.63% |
| 5 | Consumer Discretionary | 8.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3001
Rocky Brands
RCKY
$304M
| $719K | ﹤0.01% |
18,580
-2,625
| -12% | -$95.6K |
|
3002
Cadiz
CDZI
$266M
| $710K | ﹤0.01% |
144,505
-16,730
| -10% | -$91.4K |
|
3003
Alico
ALCO
$286M
| $708K | ﹤0.01% |
17,170
-247
| -1% | -$9.81K |
|
|
DDI
3004
DoubleDown Interactive
DDI
$566M
| $706K | ﹤0.01% |
83,598
-12,677
| -13% | -$111K |
|
3005
iShares Intermediate Government/Credit Bond ETF
GVI
$3.72B
| $694K | ﹤0.01% |
6,510
+3,367
| +107% | +$361K |
|
3006
Vanguard Health Care ETF
VHT
$18.2B
| $694K | ﹤0.01% |
2,550
-105
| -4% | -$30K |
|
3007
LoveSac
LOVE
$239M
| $693K | ﹤0.01% |
46,910
+5,724
| +14% | +$75.8K |
|
|
VOXR
3008
Vox Royalty Corp
VOXR
$301M
| $690K | ﹤0.01% |
131,631
-13,954
| -10% | -$74.7K |
|
3009
Monopar Therapeutics
MNPR
$736M
| $688K | ﹤0.01% |
12,558
-1,727
| -12% | -$104K |
|
3010
Radiant Logistics
RLGT
$416M
| $681K | ﹤0.01% |
96,586
-8,034
| -8% | -$56.4K |
|
|
ONL
3011
Orion Office REIT
ONL
$148M
| $678K | ﹤0.01% |
315,337
+1,984
| +0.6% | +$4.59K |
|
3012
FS Bancorp
FSBW
$324M
| $677K | ﹤0.01% |
17,556
-1,273
| -7% | -$51.8K |
|
|
WW
3013
WW International
WW
$133M
| $677K | ﹤0.01% |
+49,299
| New | +$1.1M |
|
3014
TaskUs
TASK
$506M
| $677K | ﹤0.01% |
100,830
+553
| +0.6% | +$5.85K |
|
3015
Vanguard Financials ETF
VFH
$13.3B
| $670K | ﹤0.01% |
5,545
+69
| +1% | +$8.8K |
|
3016
National Bankshares
NKSH
$233M
| $669K | ﹤0.01% |
18,375
-9,478
| -34% | -$346K |
|
|
TONX
3017
TON Strategy Co
TONX
$183M
| $669K | ﹤0.01% |
270,797
+41,760
| +18% | +$105K |
|
3018
AMES National
ATLO
$266M
| $665K | ﹤0.01% |
23,568
-3,195
| -12% | -$83.7K |
|
3019
First Community Corp
FCCO
$316M
| $661K | ﹤0.01% |
22,621
+597
| +3% | +$17.5K |
|
3020
The Oncology Institute
TOI
$498M
| $660K | ﹤0.01% |
214,915
+6,650
| +3% | +$20.4K |
|
|
BLFY
3021
DELISTED
Blue Foundry Bancorp
BLFY
| $659K | ﹤0.01% |
49,739
-6,040
| -11% | -$79.9K |
|
3022
ChargePoint
CHPT
$133M
| $659K | ﹤0.01% |
135,499
+334
| +0.2% | +$2.03K |
|
3023
Falcon's Beyond
FBYD
$514M
| $655K | ﹤0.01% |
46,426
+2,596
| +6% | +$18.8K |
|
3024
Larimar Therapeutics
LRMR
$416M
| $654K | ﹤0.01% |
145,342
-16,771
| -10% | -$67K |
|
3025
Benitec Biopharma
BNTC
$394M
| $654K | ﹤0.01% |
61,411
+16,137
| +36% | +$187K |
|
Similar funds
Charles Schwab's Q1 2026 Portfolio in Review
As of Q1 2026, Charles Schwab held 3,535 positions worth $654B, up 1.7% from $644B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Charles Schwab deployed $21.4B of net new capital in Q1 2026, opening 79 new positions and adding to 1,903 existing holdings. Its largest new stake was JPMorgan Income ETF: 8,679,689 shares worth $400M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Cisco, an estimated $2.86B trimmed.
- Charles Schwab's largest Q1 2026 buy was JPMorgan Income ETF: 8,679,689 shares worth $400M.
- Charles Schwab added most to UnitedHealth in Q1 2026, an estimated $3.69B increase.
- Charles Schwab's biggest Q1 2026 reduction was Cisco, cutting an estimated $2.86B.
- Charles Schwab fully exited Comerica in Q1 2026, selling an estimated $412M.
- Charles Schwab's ten largest holdings make up 22% of its $654B portfolio in Q1 2026.
- Charles Schwab opened 79 new positions and closed 80 in Q1 2026.
- Charles Schwab's portfolio value rose 1.7% quarter-over-quarter to $654B.
Based on Charles Schwab's 13F filing for Q1 2026, filed 15 May 2026.